According to Sanara MedTech's latest financial reports the company's current EPS (TTM) is -$1.05. In 2022 the company made an earnings per share (EPS) of -$1.00 an increase over its 2021 EPS that were of -$1.08.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.05 | 5% |
2022 | -$1.00 | -7.41% |
2021 | -$1.08 | 54.42% |
2020 | -$0.70 | -46.19% |
2019 | -$1.30 | 267.96% |
2018 | -$0.35 | -303.82% |
2017 | $0.17 | -127.69% |
2016 | -$0.63 | -58.48% |
2015 | -$1.51 | -45.91% |
2014 | -$2.79 | -45.64% |
2013 | -$5.13 | 86.78% |
2012 | -$2.75 | -89.74% |
2011 | -$26.77 | 33.85% |
2010 | -$20.00 | 100% |
2009 | -$10.00 | 25% |
2008 | -$8.00 | 158.06% |
2007 | -$3.10 | -18.42% |
2006 | -$3.80 | -24% |
2005 | -$5.00 | -73.72% |
2004 | -$19.02 | |
2001 | -$3.54 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -74.29% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -4.76% | ๐บ๐ธ USA |